mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.16 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.2 |